Zobrazeno 1 - 10
of 14
pro vyhledávání: '"SARA VELAYATI"'
Autor:
Sara Velayati, Ahmed Elsakka, Ken Zhao, Joseph P. Erinjeri, Brett Marinelli, Mohamed Soliman, Olivier Chevallier, Etay Ziv, Lynn A. Brody, Constantinos T. Sofocleous, Stephen B. Solomon, James J. Harding, Ghassan K. Abou-Alfa, Michael I. D’Angelica, Alice C. Wei, Peter T. Kingham, William R. Jarnagin, Hooman Yarmohammadi
Publikováno v:
Current Oncology, Vol 30, Iss 10, Pp 9181-9191 (2023)
The safety and efficacy of hepatic artery embolization (HAE) in treating intrahepatic cholangiocarcinoma (IHC) was evaluated. Initial treatment response, local tumor progression-free survival (L-PFS), and overall survival (OS) were evaluated in 34 IH
Externí odkaz:
https://doaj.org/article/7cbeab7a43d54e31aadc95f47c6af60a
Autor:
Sara Velayati, Alexander Belkin, Gurwinder Sidhu Kumar, Zubin J Tharayil, Neeru Kumar, Samir Patel
Publikováno v:
Journal of Community Hospital Internal Medicine Perspectives, Vol 11, Iss 5, Pp 698-702 (2021)
Amyloidosis involves the deposition of abnormal proteins in various tissues and results in progressive organ dysfunction, commonly affecting multiple organs. Two types of systemic amyloidosis are AA and AL; the former is associated with acute phase r
Externí odkaz:
https://doaj.org/article/e4d06fc0260748a98203c6198befdcc7
Autor:
Sara Velayati, Joseph P. Erinjeri, Lynn A. Brody, Etay Ziv, Franz E. Boas, Karen T. Brown, Anne M. Covey, George I. Getrajdman, Stephen B. Solomon, Peter T. Kingham, William D. Tap, William R. Jarnagin, Hooman Yarmohammadi
Publikováno v:
Sarcoma, Vol 2019 (2019)
The aim of this study was to evaluate safety and survival following hepatic artery embolization (HAE) for metastatic solitary fibrous tumor (SFT) in the liver. All patients with SFT metastatic to liver treated with HAE were retrospectively analyzed.
Externí odkaz:
https://doaj.org/article/573c739f82e9479e97325ae56b759177
Autor:
Alexander Belkin, Sara Velayati, Yordan Jimenez-Perez, Zubin Tharayil, Ravi Gupta, Kenneth Lidonnici, Samir Patel
Publikováno v:
Journal of Community Hospital Internal Medicine Perspectives. 12:83-88
Autor:
Neeru Kumar, Samir Patel, Sara Velayati, Zubin J Tharayil, Gurwinder Sidhu Kumar, Alexander Belkin
Publikováno v:
Journal of Community Hospital Internal Medicine Perspectives, Vol 11, Iss 5, Pp 698-702 (2021)
Journal of Community Hospital Internal Medicine Perspectives
article-version (VoR) Version of Record
Journal of Community Hospital Internal Medicine Perspectives
article-version (VoR) Version of Record
Amyloidosis involves the deposition of abnormal proteins in various tissues and results in progressive organ dysfunction, commonly affecting multiple organs. Two types of systemic amyloidosis are AA and AL; the former is associated with acute phase r
Autor:
Vicky Makker, Constantinos T. Sofocleous, Lynn A. Brody, Joseph P. Erinjeri, Etay Ziv, Ahmed Elsakka, Franz E. Boas, William P. Tew, Sara Velayati, Hooman Yarmohammadi, Eduardo A. Lacayo, Mikhail Silk
Publikováno v:
J Vasc Interv Radiol
Purpose To evaluate the safety and efficacy of 2 locoregional therapies (LRTs) including hepatic artery embolization (HAE) and transarterial radioembolization (TARE) in the treatment of patients with metastatic ovarian cancer to the liver. Material a
Publikováno v:
Diabetes. 71
Introduction: Maturity onset diabetes of the young (MODY) is a monogenic nonimmune type of diabetes mellitus. It is rare and sometimes misdiagnosed as type 1 or type 2 diabetes (T2DM) . The age of onset is usually below 25 years. It is more common in
Publikováno v:
Diabetes. 71
Introduction: Latent autoimmune diabetes in adults (LADA) is atypical heterogenic diabetes that is frequently misdiagnosed as type 2 diabetes (T2DM) . LADA can demonstrate features of type 1 or T2DM.1 The diagnosis of LADA is well established, howeve
Autor:
George I. Getrajdman, Hooman Yarmohammadi, Juliana Schilsky, Nadia Petre, Ulrika Asenbaum, Joel Sheinfeld, Jeremy C. Durack, Ernesto Santos, Stephen B. Solomon, Sara Velayati, Joseph P. Erinjeri, Lynn A. Brody, Adrian J. Gonzalez-Aguirre
Publikováno v:
J Urol
PURPOSE: To investigate the efficacy and analyze the complication risk factors of peritoneovenous shunt (PVS) in treating refractory chylous ascites (CA) following retroperitoneal lymph node dissection (RPLND) in patients with urologic malignancies.
Publikováno v:
Journal of the Endocrine Society. 6:A221-A221
Introduction Recurrent or persistent primary hyperparathyroidism has been reported in 2-5% of patients after the initial operation. Reoperations have been associated with significant complications. The aim of this presentation is to highlight the imp